Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells
Martin S. Spitzer, Efdal Yoeruek, Ana Sierra, Barbara Wallenfels-Thilo, Ulrich Schraermeyer, Bernhard Spitzer, Karl U. Bartz-Schmidt, Peter SzurmanVolume:
245
Language:
english
Pages:
6
DOI:
10.1007/s00417-007-0568-7
Date:
December, 2007
File:
PDF, 262 KB
english, 2007